Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anavex, Aptorum, Biomarin, Cara, Dynavax, Ensysce, Galmed, Gemini, Hutchmed, Khondrion, Lianbio, Merck & Co., Molecular Partners, Nordic, Novartis, Ocugen, Regenxbio, Roche, Sarepta, Sernova, Theravance, Theseus, Viking.